State-of-the-Art GMP Manufacturing RNA Cell Therapies With Cartesian's CEO
Source: Cell & Gene
![21_06_cgpodcast_1200x628_ep4 21_06_cgpodcast_1200x628_ep4](https://vertassets.blob.core.windows.net/image/43c997da/43c997da-9304-4cd2-a523-81c125967e34/375_250-21_06_cgpodcast_1200x628_ep4.png)
Dr. Murat Kalayoglu, CEO at Cartesian Therapeutics, details the cell and gene therapy sector's advancements in RNA cell therapy and the why behind the company's decision to build its own wholly-owned GMP manufacturing facility.
This website uses cookies to ensure you get the best experience on our website. Learn more